Mangalam Drugs & Organics Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Mangalam Drugs And Organics Limited
Symbol
MANGALAM
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Not Applicable
Board Composition
No
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
17-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Managing Director
Designation Of Person Affirmations
Managing Director
Designation Of Person For Annual Affirmations
Managing Director
Designation Of Person For Quartely Affirmations
Managing Director
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Details Of Non Compliance Of Board Composition
Being resignation of 1 Independent Director of the Company, due to which criteria for minimum strength of Board Composition falls below. The Company is in process of appointment of Independednt Director.
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.mangalamdrugs.com/investors/
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.mangalamdrugs.com/shareholders-information-other-details/
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.mangalamdrugs.com/shareholders-information-other-details/
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.mangalamdrugs.com/investors-2/#n
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.mangalamdrugs.com/investors-2/#n
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.mangalamdrugs.com/company-profile/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.mangalamdrugs.com/wp-content/uploads/2022/08/Whistle-Blower-Policy.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.mangalamdrugs.com/financial-results/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.mangalamdrugs.com/wp-content/uploads/2022/08/Policy-for-Determining-Material-Subsidiary.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.mangalamdrugs.com/wp-content/uploads/2022/08/Policy-on-Related-Party-Transaction_MDOL.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.mangalamdrugs.com/shareholding-pattern/
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.mangalamdrugs.com/investors/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.mangalamdrugs.com/investors-2/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.mangalamdrugs.com/investors/
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.mangalamdrugs.com/
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.mangalamdrugs.com/investors-2/
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.mangalamdrugs.com/investors/
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Not Applicable
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE584F01014
Market Capitalisation As Per Immediate Previous Financial Year
Any other
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
GOVARDHAN MURLIDHAR DHOOT
Name Of Signatory Affirmations
GOVARDHAN MURLIDHAR DHOOT
Name Of Signatory For Annual Affirmations
GOVARDHAN MURLIDHAR DHOOT
Name Of Signatory For Quartely Affirmations
GOVARDHAN MURLIDHAR DHOOT
Name Of The Company
MANGALAM DRUGS AND ORGANICS LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
Since the Company has not given loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them, the affirmation is not applicable.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Not Applicable
SCORES Registration ID
M00084
Scrip Code
532637
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
MANGALAM
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
No
Chairperson Related to MD / CEO
Yes
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentCessationTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrGOVARDHAN MURLIDHAR DHOOT******01240086Executive DirectorChairpersonMD21-Oct-1953NoActiveNot Applicable16-Apr-199601-Nov-20241020
2MrBRIJMOHAN MURLIDHAR DHOOT******01046420Executive DirectorNot Applicable10-Jul-1951NoActiveNot Applicable02-May-201514-Aug-20241010
3MrsNIDHI SHANTANU MUNDADA******08134952Non-Executive - Independent DirectorNot Applicable20-Sep-1988NoActiveNot Applicable28-May-201828-May-2023941122
4MrPRAVEEN SAXENA******03199264Non-Executive - Independent DirectorNot Applicable01-Jun-1955NoActiveNot Applicable21-Mar-202121-Mar-2026601110
5MrRAKESH KISHINCHAND MILWANI******01115469Non-Executive - Non Independent DirectorNot Applicable11-Oct-1961NoActiveNot Applicable10-Mar-202210-Mar-2022481000
6MrRUKMESH PRABHUKUMAR DHANDHANIA******02493968Non-Executive - Independent DirectorNot Applicable28-Dec-1979NoActiveNot Applicable20-Nov-201720-Nov-202216-Jan-202697.160000

Committee Disclosures

Entry CompComit14
Date of Appointment
12-Aug-2021
Entry CompComit15
Date of Appointment
16-Apr-2014
Entry CompComit16
Date of Appointment
21-Dec-2021
Date Of Cessation Of Director In Committee
16-Jan-2026
Entry CompComit17
Date of Appointment
06-Feb-2026
Entry CompComit41
Date of Appointment
02-Dec-2020
Entry CompComit42
Date of Appointment
20-Nov-2017
Entry CompComit43
Date of Appointment
06-Feb-2026
Entry CompComit44
Date of Appointment
21-Dec-2021
Date Of Cessation Of Director In Committee
16-Jan-2026
Entry CompComit68
Date of Appointment
21-Dec-2021
Entry CompComit69
Date of Appointment
16-Apr-2014
Entry CompComit70
Date of Appointment
02-Dec-2020
Entry MainD
Composition And Role Of Risk Management Committee
Not Applicable
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.mangalamdrugs.com/wp-content/uploads/2022/08/Terms-of-Reference-of-all-Committees.pdf
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
No
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Not Applicable
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
No
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
08134952
Member Name
NIDHI SHANTANU MUNDADA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
01240086
Member Name
GOVARDHAN MURLIDHAR DHOOT
Position
Executive Director

Audit Committee

Additional Position
Member
Director DIN
02493968
Member Name
RUKMESH PRABHUKUMAR DHANDHANIA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
03199264
Member Name
PRAVEEN SAXENA
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Audit Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
08134952
Member Name
NIDHI SHANTANU MUNDADA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
03199264
Member Name
PRAVEEN SAXENA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
01115469
Member Name
RAKESH KISHINCHAND MILWANI
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
02493968
Member Name
RUKMESH PRABHUKUMAR DHANDHANIA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Nomination and remuneration committee

Nomination and remuneration committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
08134952
Member Name
NIDHI SHANTANU MUNDADA
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
01240086
Member Name
GOVARDHAN MURLIDHAR DHOOT
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
01046420
Member Name
BRIJMOHAN MURLIDHAR DHOOT
Position
Executive Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Not Applicable
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Not Applicable
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Not Applicable
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
20-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
6
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
15-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
55
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
6
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
21
Number Of Directors Present In Meeting Of Board Of Directors
5
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
5
Entry MeetingBOD4
Dates Of Meeting If Any In The Relevant Quarter
26-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
47
Number Of Directors Present In Meeting Of Board Of Directors
5
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
5
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
20-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
15-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
55
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
21
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
20-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
15-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
55
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
21
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Relevant Quarter
26-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
47
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Previous Quarter
20-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.mangalamdrugs.com/investors/#n
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.mangalamdrugs.com/investors/#n
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Entry D_AcquisitionShares1
Percentage Of Shares Or Voting Rights Acquired During The Quarter
0
Entry I_AcquisitionShares_PY1
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry I_AcquisitionShares1
Date Of Acquisition
30-Sep-2023
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
MANGALAM LABORATORIES PRIVATE LIMITED
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry MainD
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Reason For Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Not Applicable To The Entity
No ongoing dispute or Tax Litigation is there.
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
No
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
There is no any fine or penalty imposed on Company.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No